FUSIONSPROTEINE MIT ALBUMINBINDUNGSDOMÄNE

European patent · EP3583125 · In force

Register entry

Publication number
EP3583125
Application number
EP18710585
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Feb 20, 2018
Published
Dec 25, 2019
Granted
Jan 22, 2025
Protection ends at the latest
Feb 19, 2038
Next annual fee due
Feb 28, 2027
IPC classes
C07K 16/18 (2006.01)
C07K 14/715 (2006.01)
A61K 38/20 (2006.01)
A61K 39/395 (2006.01)
C07K 16/22 (2006.01)
C07K 16/28 (2006.01)
A61P 35/00 (2006.01)
Priority
US 201762459975 P 16.02.2017
US 201762459981 P 16.02.2017
PCT application
PCT/US2018/000085 20.02.2018
PCT publication
WO2018/151868 23.08.2018
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Mar 1, 2026

    Change

    Published in Swissreg on 01.03.2026

  2. Dec 3, 2025

    Change

    Published in Swissreg on 03.12.2025

  3. Mar 31, 2025

    Agent entered

    Representative
    Murgitroyd & Company, Geneva Rhone 8 Sàrl, Rue du Commerce 4, 1204 Genève

    Published in Swissreg on 31.03.2025

  4. Mar 6, 2025

    Change

    Published in Swissreg on 06.03.2025

  5. Jan 22, 2025

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 22.01.2025

Parties

Holder

Sonnet BioTherapeutics, Inc.

100 Overlook Center, Suite 102, Princeton, NJ 08540, US

Agent

Murgitroyd & Company

Geneva Rhone 8 Sàrl Rue du Commerce 4, 1204 Genève

Inventor

CINI, John, K.

Blairstown, NJ 07825, US

HUANG, Haomin

Yardley, PA 19067, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.